Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 (Voluven) on renal function as priming solutions for cardiopulmonary bypass: A randomized double blind clinical trial

Anesthesiology and Pain Medicine

Volumn 6, Issue 1, 2016, Pages 1-6

  Maleki, Mahmood Hosseinzadeh ^a   Derakhshan, Pooya ^b   Sharifabad, Amir Rahmanian ^a   Amouzeshi, Ahmad ^a  

^a BIRJAND UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Albumin; Cardiopulmonary bypass

Indexed keywords

ALBUMIN; ANTITHROMBOCYTIC AGENT; ASPARTIC ACID; ATORVASTATIN; CISATRACURIUM; ETOMIDATE; HEPARIN; HETASTARCH; MORPHINE; SUFENTANIL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANESTHESIA INDUCTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CLOTTING; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; DIURETIC THERAPY; DOUBLE BLIND PROCEDURE; ELECTROLYTE DISTURBANCE; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODYNAMIC PARAMETERS; HUMAN; HYPERSENSITIVITY; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MEMBRANE OXYGENATOR; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY;

EID: 84949024537     PISSN: 22287523     EISSN: 22287531     Source Type: Journal    
DOI: 10.5812/aapm.30326     Document Type: Article

References (32)

1. Choi YS, Shim JK, Hong SW, Kim JC, Kwak YL. Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass. Minerva Anestesiol. 2010;76(8):584-91.[PubMed: 20661198]
2. Himpe D. Colloids versus crystalloids as priming solutions for cardiopulmonary bypass: a meta-analysis of prospective, randomised clinical trials. Acta Anaesthesiol Belg. 2003;54(3):207-15.[PubMed: 14598617]
3. Langeron O, Doelberg M, Ang E, Bonnet F, Capdevila X, Coriat P. Voluven??, a Lower Substituted Novel Hydroxyethyl Starch (HES 130/0.4), Causes Fewer Effects on Coagulation in Major Orthopedic Surgery than HES 200/0.5. Anesth Analg. 2001:855-62. doi: 10.1097/00000539-200104000-00011.[PubMed: 11273914]
4. Gallandat Huet RC, Siemons AW, Baus D, van Rooyen-Butijn WT, Haagenaars JA, van Oeveren W, et al. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth. 2000;47(12):1207-15.[PubMed: 11132743]
5. Arellano R, Gan BS, Salpeter MJ, Yeo E, McCluskey S, Pinto R, et al. A triple-blinded randomized trial comparing the hemostatic effects of large-dose 10% hydroxyethyl starch 264/0.45 versus 5% albumin during major reconstructive surgery. Anesth Analg. 2005;100(6):1846-53. doi: 10.1213/01.ANE.0000152008.04333.53.[PubMed: 15920225]
6. Baldassarre S, Vincent JL. Coagulopathy induced by hydroxyethyl starch. Anesth Analg. 1997;84(2):451-3.[PubMed: 9024047]
7. Cope JT, Banks D, Mauney MC, Lucktong T, Shockey KS, Kron IL, et al. Intraoperative hetastarch infusion impairs hemostasis after cardiac operations. Ann Thorac Surg. 1997;63(1):78-82.[PubMed: 8993245]
8. Payani N, Foroughi M, Dabbagh A. The Effect of Intravenous Administration of Active Recombinant Factor VII on Postoperative Bleeding in Cardiac Valve Reoperations; A Randomized Clinical Trial. Anesth Pain Med. 2015;5(1):e22846. doi: 10.5812/aapm.22846.[PubMed: 25789239]
9. Knutson JE, Deering JA, Hall FW, Nuttall GA, Schroeder DR, White RD, et al. Does Intraoperative Hetastarch Administration Increase Blood Loss and Transfusion Requirements After Cardiac Surgery? Anesth Analg. 2000;9(4):801-7. doi: 10.1097/00000539-200004000-00006.[PubMed: 10735779]
10. Navickis RJ, Haynes GR, Wilkes MM. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials. J Thorac Cardiovasc Surg. 2012;144(1):223-30. doi: 10.1016/j.jtcvs.2012.04.009.[PubMed: 22578894]
11. Niemi TT, Suojaranta-Ylinen RT, Kukkonen SI, Kuitunen AH. Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg. 2006;102(4):998-1006. doi: 10.1213/01.ane.0000200285.20510.b6.[PubMed: 16551888]
12. Onorati F, Santarpino G, Renzulli A, De Feo M, De Santo LS, Della Corte A, et al. Does priming implementation with low-dose albumin reduce postoperative bleeding following cardiopulmonary bypass? Int J Artif Organs. 2003;26(3):211-6.[PubMed: 12703887]
13. Tigchelaar I, Huet RCG, Boonstra PW, van Oeveren W. Comparison of three plasma expanders used as priming fluids in cardiopulmonary bypass patients. Perfusion. 1998;13(5):297-303. doi: 10.1177/026765919801300503.[PubMed: 9778712]
14. Vanhoonacker J, Ongenae M, Vanoverschelde H, Donadoni R. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG. Acta Anaesthesiol Belg. 2009;60(2):91-7.[PubMed: 19594090]
15. Wiesen P, Canivet JL, Ledoux D, Roediger L, Damas P. Effect of hydroxyethylstarch on renal function in cardiac surgery: a large scale retrospective study. Acta Anaesthesiol Belg. 2005;56(3):257-63.[PubMed: 16265828]
16. Frenette AJ, Bouchard J, Bernier P, Charbonneau A, Nguyen LT, Rioux JP, et al. Albumin administration is associated with acute kidney injury in cardiac surgery: a propensity score analysis. Crit Care. 2014;18(6):602. doi: 10.1186/s13054-014-0602-1.[PubMed: 25394836]
17. Kumar AB, Suneja M. Cardiopulmonary bypass-associated acute kidney injury. Anesthesiology. 2011;114(4):964-70. doi: 10.1097/ALN.0b013e318210f86a.[PubMed: 21394005]
18. Joudi M, Fathi M, Soltani G, Izanloo A. Factors affecting on serum lactate after cardiac surgery. Anesth Pain Med. 2014;4(4):e18514. doi: 10.5812/aapm.18514.[PubMed: 25632379]
19. Wilkes MM, Navickis RJ. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med. 2001;135(3):149-64.[PubMed: 11487482]
20. Bellomo R, Auriemma S, Fabbri A, D'Onofrio A, Katz N, McCullough PA, et al. The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI). Int J Artif Organs. 2008;31(2):166-78.[PubMed: 18311733]
21. Tiryakioglu O, Yildiz G, Vural H, Goncu T, Ozyazicioglu A, Yavuz S. Hydroxyethyl starch versus Ringer solution in cardiopulmonary bypass prime solutions (a randomized controlled trial). J Cardiothorac Surg. 2008;3:45. doi: 10.1186/1749-8090-3-45.[PubMed: 18620591]
22. Sakpal TV. Sample size estimation in clinical trial. Perspect Clin Res. 2010;1(2):67-9.[PubMed: 21829786]
23. Kuitunen AH, Hynynen MJ, Vahtera E, Salmenpera MT. Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery. Anesth Analg. 2004;98(2):291-7.[PubMed: 14742357]
24. Brinkman AC, Romijn JW, van Barneveld LJ, Greuters S, Veerhoek D, Vonk AB, et al. Profound effects of cardiopulmonary bypass priming solutions on the fibrin part of clot formation: an ex vivo evaluation using rotation thromboelastometry. J Cardiothorac Vasc Anesth. 2010;24(3):422-6. doi: 10.1053/j.jvca.2009.10.018.[PubMed: 20056447]
25. Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg. 2001;72(2):527-33.[PubMed: 11515893]
26. Skhirtladze K, Base EM, Lassnigg A, Kaider A, Linke S, Dworschak M, et al. Comparison of the effects of albumin 5%, hydroxyethyl starch 130/0.4 6%, and Ringer's lactate on blood loss and coagulation after cardiac surgery. Br J Anaesth. 2014;112(2):255-64. doi: 10.1093/bja/aet348.[PubMed: 24169821]
27. Tigchelaar I, Gallandat Huet RC, Korsten J, Boonstra PW, van Oeveren W. Hemostatic effects of three colloid plasma substitutes for priming solution in cardiopulmonary bypass. Eur J Cardiothorac Surg. 1997;11(4):626-32.[PubMed: 9151028]
28. Van Der Linden P, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesth Analg. 2013;116(1):35-48. doi: 10.1213/ANE.0b013e31827175da.[PubMed: 23115254]
29. Warren BB, Durieux ME. Hydroxyethyl starch: safe or not. Anesth Analg. 1997;84(1):206-12.[PubMed: 8989026]
30. Weiskopf RB. Equivalent efficacy of hydroxyethyl starch 130/0.4 and human serum albumin: if nothing is the same, is everything different? The importance of context in clinical trials and statistics. Anesthesiology. 2013;119(6):1249-54. doi: 10.1097/ALN.0000000000000021.[PubMed: 24126265]
31. de Jonge E, Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med. 2001;29(6):1261-7.[PubMed: 11395618]
32. Van der Linden P, De Ville A, Hofer A, Heschl M, Gombotz H. Six percent hydroxyethyl starch 130/0.4 (Voluven(R)) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients. Anesthesiology. 2013;119(6):1296-309. doi: 10.1097/ALN.0b013e3182a6b387.[PubMed: 23934169]